Centre Hospitalier Intercommunal de Créteil - Service de Pneumologie

Créteil

0 studies enrolling now · 3 studies all time

What they study most

Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Small-cell Lung Cancer

Studies at this site

• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) — Running, not enrolling
• Berzosertib + Topotecan in Relapsed Platinum-Resistant Small-Cell Lung Cancer (DDRiver SCLC 250) — Completed